Short Bowel Syndrome Market Is Estimated To Witness High Growth Owing To High cost of immunotherapy treatment
The Short Bowel Syndrome Market is estimated to be valued at US$ 188.9 Bn in 2023 and is expected to exhibit a CAGR of 11.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Read More